Suppr超能文献

即时检测肌酐设备在肾移植患者趋势监测中的应用:是否适用?

Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?

作者信息

van Lint Céline L, van der Boog Paul J M, Romijn Fred P H T M, Schenk Paul W, van Dijk Sandra, Rövekamp Ton J M, Kessler Anja, Siekmann Lothar, Rabelink Ton J, Cobbaert Christa M

出版信息

Clin Chem Lab Med. 2015 Sep 1;53(10):1547-56. doi: 10.1515/cclm-2014-0932.

Abstract

BACKGROUND

The StatSensor® Xpress-i™, a point-of-care system for blood creatinine measurement, offers patients the possibility of self-monitoring creatinine. In this study, the analytical performance of the StatSensor® for both detecting current renal function and monitoring renal (dys)function in kidney transplant patients was examined.

METHODS

Accuracy of the StatSensor® with capillary and venous whole blood was evaluated and compared to an isotopic dilution mass spectrometry (IDMS)-traceable enzymatic creatinine test in venous serum (n=138). Twenty Li-heparin samples were compared to the IDMS reference method performed by a Joint Committee for Traceability in Laboratory Medicine (JCTLM)-listed reference laboratory (RfB, Bonn, Germany). To evaluate StatSensor®'s suitability to monitor kidney function, both venous and capillary samples were obtained in 20 hospitalized transplantation patients. Venous samples were analyzed with an IDMS-traceable enzymatic test, capillary samples were measured using the StatSensor®. For all 2-day intervals, percentage change in creatinine was compared between both methods.

RESULTS

The StatSensor® did not meet total allowable error criterion of 6.9%. Average overall CVa for the StatSensor® was 10.4% and 5.2% for capillary and venous whole blood results, respectively. Overall CVa for the central laboratory serum creatinine method was <1.5%. For monitoring renal (dys)function, total agreement of the StatSensor® with an IDMS-traceable enzymatic test was 68% using a 10% Δ change. No significant differences were found between the changes observed by both methods.

CONCLUSIONS

Capillary blood testing with the StatSensor® is not advisable for determining current renal function with a single creatinine measurement in kidney transplant patients, mainly due to excessive analytical imprecision. However, our results suggest that capillary blood testing with the StatSensor® can be used for daily trend monitoring of kidney function after renal transplantation.

摘要

背景

StatSensor® Xpress-i™是一种用于测量血肌酐的即时检测系统,可为患者提供自我监测肌酐的可能性。在本研究中,对StatSensor®在检测肾移植患者当前肾功能和监测肾(功能)异常方面的分析性能进行了检测。

方法

评估了StatSensor®在毛细管血和静脉全血中的准确性,并与静脉血清中可溯源至同位素稀释质谱法(IDMS)的酶法肌酐检测进行比较(n = 138)。将20份锂肝素样本与由实验室医学溯源联合委员会(JCTLM)认可的参考实验室(德国波恩的RfB)执行的IDMS参考方法进行比较。为评估StatSensor®监测肾功能的适用性,在20名住院移植患者中采集了静脉血和毛细管血样本。静脉样本采用可溯源至IDMS的酶法检测,毛细管样本使用StatSensor®进行测量。在所有为期2天的时间段内,比较了两种方法之间肌酐的百分比变化。

结果

StatSensor®未达到6.9%的总允许误差标准。StatSensor®毛细管血和静脉全血结果的平均总体变异系数(CVa)分别为10.4%和5.2%。中心实验室血清肌酐方法的总体CVa<1.5%。对于监测肾(功能)异常,使用10%的变化量时,StatSensor®与可溯源至IDMS的酶法检测的总一致性为68%。两种方法观察到的变化之间未发现显著差异。

结论

对于肾移植患者,不建议使用StatSensor®通过单次肌酐测量来确定当前肾功能,主要原因是分析不精密度过高。然而,我们的结果表明,使用StatSensor®进行毛细管血检测可用于肾移植后肾功能的日常趋势监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验